LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: Sales of lateral flow assays in clinical testing are expected to register a CAGR of 5% through 2032 (Photo courtesy of Pexels)

Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications

The global lateral flow assays market is projected to register a CAGR of 4.7% during 2022-2032 to surpass USD 11.7 billion by the end of 2032, driven by the growing prevalence of influenza, STDs, and tuberculosis worldwide and rising awareness among people about the availability of POCT kits. More...
12 May 2022
Image: Global rapid test kits market will surpass USD 52 billion in 2030 (Photo courtesy of Pexels)

Global Rapid Test Kits Market Driven by Immunoassay and Chromatography-Based Tests

The global rapid test kits market size was valued at more than USD 25.50 billion in 2021 and is expected to register a CAGR of 8.1% over the 2019-2030 period to surpass USD 52 billion in 2030, driven primarily by the increasing prevalence of various infectious diseases. More...
11 May 2022
Image: EUPROTEIN offers custom development and production of bioresearch reagents (Photo courtesy of EUPROTEIN)

Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities

Meridian Bioscience, Inc. (Cincinnati, OH, USA) has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. (North Brunswick Township, NJ, USA). More...
03 May 2022
Image: L Squared Capital Partners has acquired Globe Scientific (Photo courtesy of Pexels)

Globe Scientific Acquired by L Squared Capital Partners

Globe Scientific (Mahwah, NJ, USA), a provider of laboratory consumable supplies, has been acquired by L Squared Capital Partners (Newport Beach, CA, USA), marking its third acquisition as part of GSI Group Holdings. More...
02 May 2022
Image: Xpert MTB/RIF proved to be a game-changer in the TB epidemic (Photo courtesy of Cepheid)

Study Examines Global Rollout of Rapid Molecular Tests for TB Over Last 12 Years

Diagnostic tests only have an impact on health if they are put to use in a correct and timely manner. To ensure diagnostics are accessible and utilized, a new qualitative evidence synthesis review has pulled together all relevant research to date on rapid molecular tests for tuberculosis and tuberculosis drug resistance. More...
27 Apr 2022
Image: Rising prevalence of chronic diseases is driving the global POCT market (Photo courtesy of Pexels)

Global Point-of-Care Testing (POCT) Market to Surpass USD 55 Billion by 2030

The global point of care testing (POCT) market was valued at USD 29.47 billion in 2020 and is expected to grow at a CAGR of 6.5% from 2021 to 2030 to reach USD 55.27 billion by 2030, driven by a rise in the prevalence of chronic diseases such as diabetes, rheumatism, and cancer and several supportive initiatives implemented by government and non-government organizations. More...
19 Apr 2022
Image: bioMérieux has entered into an agreement to acquire Specific Diagnostics (Photo courtesy of Pexels)

BioMérieux Acquires Antibiotic Susceptibility Test Firm Specific Diagnostics

bioMérieux (Marcy-l'Étoile, France) has further strengthened its commitment to fight AMR with the acquisition of Specific Diagnostics (San Jose, CA, USA) which focuses on fast AST solution and has developed a rapid AST system that delivers phenotypic AST directly from positive blood cultures. More...
13 Apr 2022
Visit expo >
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA

In Other News



LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000 - 2025 Globetech Media.
All rights reserved.